González FI, Barbolla L

Language: Spanish
References: 8
Page: 147-150
PDF size: 168.11 Kb.

Text Extraction

No Abstract

REFERENCES

1. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl

2. Glynn SA, Kleinman SH, Wright DJ, Busch MP. International application of the incidence rate/window period model. Transfusion. 2002;42:966-972.

3. Álvarez M, Oyonarte S, Rodríguez PM, Hernández JM. Estimated risk of transfusion-transmitted viral infections in Spain. Transfusion 2002;42:994-998.

4. Eiras A, Sauleda S, Planelles D, et al. HCV screening in blood donations using RT-PCR in mini-pool: the experience in Spain after routine use for 2 years. Transfusion 2003;43:713-720.

5. Kleinman SH, Kuhns MC, Todd DS et al. Frequency of HBV DNA detection in US blood donors testing positive for the presence of anti-HBc: implications for transfusion transmission and donor screening. Transfusion 2003;43:696-704.

6. Pillonel J, Laperche S. Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing). Transfus Clin Biol 2004;11:81-86.

7. Seed CR, Cheng A, Ismay SL et al. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. Transfusion 2002;42:1365-1372.

8. Eiras A, Franco E, Montoro JA, Planelles D, Villaescusa R. HCV NAT (minipool RT-PCR) and HCV core antigen ELISA. Transfusion 2003;43:118-119.